Blood glucose meters are electronic devices that analyze a small drop of blood drawn using a lancet and lancing device. The blood is placed on a small disposable test strip that is inserted into the blood glucose meter, which reads the level of glucose in the blood. The blood glucose meter is battery-powered and fits in the palm of the hand. When the blood is placed on the strip, it flows in through capillary action. The electrochemical reaction between the test strip and the blood determines the blood glucose concentration reported as milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L).
The U.S. blood glucose meter market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose meter market was the personal segment. Personal blood glucose meters are used by individuals who manage their diabetes outside of the professional setting and monitor their blood glucose levels as a part of daily care. As the prevalence of diabetes in the U.S. increases, it is expected that the personal segment will continue to account for the majority of the total blood glucose meter market. Professional meters are used by clinicians and staff in the hospital or long term care settings to measure the blood glucose levels of their diabetic patients. Meters in the hospital are typically more technologically advanced than meters found in other settings and often involve software systems which analyze data and provide higher accuracy than personal meters. The growing number of individuals living in nursing homes or other long term care facilities who have diabetes will be the primary driver of market growth. However, as assisted living is becoming more popular, patients are opting for their own personal meters. Long term care centers are also starting to enforce ‘one patient-one meter’ policies, shifting the focus away from professional meters.
'
TABLE OF CONTENTS I
LIST OF FIGURES III
LIST OF CHARTS IV
EXECUTIVE SUMMARY 1
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 9
PROCEDURE NUMBERS 10
PROCEDURE CODES INVESTIGATED 10
MARKETS INCLUDED 11
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 INTRODUCTION 26
2.1.1 Types of Diabetes 26
2.1.2 Diabetes Complications 28
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes 30
2.1.4 Signs and Symptoms 31
2.1.5 Diabetes Monitoring 33
2.1.6 Treatment 35
2.1.7 Drug Delivery Systems 36
BLOOD GLUCOSE METER MARKET 38
3.1 INTRODUCTION 38
3.2 MARKET OVERVIEW 40
3.3 MARKET ANALYSIS AND FORECAST 44
3.3.1 Total Blood Glucose Meter Market 44
3.3.1.1 Personal Blood Glucose Meter Market 46
3.3.1.2 Professional Blood Glucose Meter Market 49
3.4 DRIVERS AND LIMITERS 51
3.4.1 Market Drivers 51
3.4.2 Market Limiters 51
3.5 COMPETITIVE MARKET SHARE ANALYSIS 54
ABBREVIATIONS 58
Chart 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013 – 2023 3
Chart 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2013 &2023 3
Chart 3 1: Blood Glucose Meter Market by Segment, U.S., 2013 – 2023 42
Chart 3 2: Blood Glucose Meter Market Breakdown, U.S., 2016 43
Chart 3 3: Blood Glucose Meter Market Breakdown, U.S.,2023 43
Chart 3 4: Total Blood Glucose Meter Market, U.S., 2013 – 2023 45
Chart 3 5: Personal Blood Glucose Meter Market, U.S., 2013 – 2023 48
Chart 3 6: Professional Blood Glucose Meter Market, U.S., 2013 – 2023 50
Chart 3 7: Leading Competitors, Blood Glucose Meter Market, U.S., 2016 57
Figure 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (1 of 2) 4
Figure 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (2 of 2) 5
Figure 1 3: Companies Researched in this Report, U.S., 2016 6
Figure 1 4: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (1 of 2) 7
Figure 1 5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (2 of 2) 8
Figure 1 6: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013 – 2016 9
Figure 1 7: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 10
Figure 1 8: Procedure Codes Investigated, U.S., 2016 10
Figure 1 9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (1 of 2) 11
Figure 1 10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (2 of 2) 12
Figure 1 11: Key Report Updates 13
Figure 1 12: Version History 13
Figure 2 1: Major Types of Diabetes and Related Pathologies, U.S., 2016 27
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2016 31
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2016 32
Figure 3 1: Blood Glucose Range Guidelines by the American Diabetes Association, U.S., 2016 39
Figure 3 2: Blood Glucose Meter Market by Segment, U.S., 2013 – 2023 (US$M) 41
Figure 3 3: Total Blood Glucose Meter Market, U.S., 2013 – 2023 44
Figure 3 4: Personal Blood Glucose Meter Market, U.S., 2013 – 2023 47
Figure 3 5: Professional Blood Glucose Meter Market, U.S., 2013 – 2023 49
Figure 3 6: Drivers and Limiters, Blood Glucose Meter Market, U.S., 2016 53
Figure 3 7: Leading Competitors, Blood Glucose Meter Market, U.S., 2016 56
Sanofi
Novo Nordisk
Eli Lilly
Medtronic
Johnson & Johnson
Becton Dickinson
Abbott
Roche
DexCom
Ascensia
Insulet
Trividia Health
Tandem
Nova Biomedical
Valeritas
